Had another look at the comparison chart, PTX has had / is trials running for their PTX 100 / 200 but if only cell therapy is considerd then the "NO Patients treated" is correct.
In fact, as CARINA isn't listed, CHM and IMU are still the only ASX listed companies having cell therapy trials running. In a time when CAR-T is so hot in the US M&A market why isn't it hot here. Must be the Southern Hemisphere, almost everything is upside down, LOL.
GLTA
CHM Price at posting:
3.4¢ Sentiment: Buy Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)